SARAH MARKWOOD: Open Payments
NPI 1255875589 · SALEM, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,760 in 87 payments from 18 companies in 2025. Trend: 2023 $1,693 · 2024 $1,548 · 2025 $1,760
Food & beverage: $1,760
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 16 | $436 |
| Novartis Pharmaceuticals Corporation | 11 | $226 |
| AstraZeneca Pharmaceuticals LP | 11 | $200 |
| BridgeBio Pharma, Inc. | 7 | $151 |
| Amgen Inc. | 9 | $137 |
| SCPHARMACEUTICALS INC. | 6 | $119 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $94 |
| Merck Sharp & Dohme LLC | 5 | $87 |
| PFIZER INC. | 4 | $64 |
| ABIOMED | 3 | $54 |
Products named: LUX-Dx Insertable Cardiac Monitor, LEQVIO, Attruby, REPATHA, FUROSCIX, WATCHMAN FLX, LifeVest, FARXIGA.
Industry payments across VA — which companies pay providers there.
